What is NDC 51662-1242?

51662-1242 is the product NDC for Naloxone Hci, Naloxone hydrochloride .4 mg/mL injection, solution, listed with the FDA by HF Acquisition Co. LLC, DBA Health First. It has 2 package NDCs, shown above in 10- and 11-digit form.

HF Acquisition Co. LLC, DBA Health First, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Naloxone Hci?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Naloxone Hci NDC 51662-1242 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1242Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1242Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51662-1242-1	51662124201	1 mL in 1 VIAL (51662-1242-1)Marketed from Aug 18, 2018
51662-1242-3	51662124203	50 POUCH in 1 CASE (51662-1242-3) / 1 mL in 1 POUCH (51662-1242-2)Marketed from Jun 15, 2020

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Naloxone Hci
Generic name (nonproprietary): naloxone hci
Active ingredients: Naloxone hydrochloride — .4 mg/mL
Dosage form: Injection, Solution
Route: Intramuscular, Intravenous, Subcutaneous
Labeler: HF Acquisition Co. LLC, DBA Health FirstNDC labeler code 51662
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 070256
Marketing start: Aug 18, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Opioid Antagonists (Mechanism)
Identifiers: Product ID 51662-1242_0ff862db-44cb-aac2-e063-6394a90a8a5dSPL ID 0ff862db-44cb-aac2-e063-6394a90a8a5dSPL set ID 73c1bad3-6ac3-8682-e053-2a91aa0a176aRxCUI 1659929UNII F850569PQR
Pharmacologic class: Opioid Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N451662124201 followed by a unit qualifier and the quantity

Package 51662-1242-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 27, 2024.

Indications (excerpt from the label)

INDICATION & USAGE Naloxone Hydrochloride Injection is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids including propoxyphene, methadone, and certain mixed agonist-antagonist analgesics: nalbuphine, pentazocine, butorphanol and cyclazocine. Naloxone hydrochloride is also indicated for the diagnosis of suspected or known acute opioid overdosage. Naloxone may be useful as an adjunctive agent to increase blood pressure in the management of septic shock ( see CLINICAL PHARMACOLOGY, Adjunctive Use in Septic Shock ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51662-1242

What is NDC 51662-1242?: 51662-1242 is the product NDC for Naloxone Hci, Naloxone hydrochloride .4 mg/mL injection, solution, listed with the FDA by HF Acquisition Co. LLC, DBA Health First. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Naloxone Hci.
What is the active ingredient?: Naloxone hydrochloride.
Who is the labeler?: HF Acquisition Co. LLC, DBA Health First, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Naloxone Hci?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under ANDA 070256

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 070256
Product	Strength	Form · route	Labeler	Product NDC
Naloxone Hydrochloride	Naloxone hydrochloride .4 mg/mL	Injection, SolutionIntramuscular, Intravenous, Subcutaneous	Hospira, Inc.	0409-1215